Skip to main content
. 2022 Mar 19;14(1):38–44. doi: 10.3390/hematolrep14010007

Table 1.

Reported case of PEL developed in adults since 2010.

No Age Sex Laboratory Data Underlying Disease Prior Treatment Reference
1 44 F pancytopenia none - Linnik et al. 2019 [6]
2 69 F pancytopenia polymyositis azathioprine Imataki et al. 2018 [7]
3 69 M bicytopenia N/A N/A Caldwell et al. 2019 [8]
4 64 F bicytopenia breast cancer chemo and radio Niscola et al. 2013 [9]
5 65 M N/A plasma cell myeloma chemo and SCT Thakral et al. 2017 [10]
6 65 M pancytopenia N/A N/A Gajendra et al. 2019 [11]
7 68 M N/A polycythemia vera chemo D. Ware et al. 2018 [12]
8 48 M pancytopenia none - Aljabry et al. 2015 [13]
9 68 M pancytopenia HIV antiretroviral drug J. Oberley et al. 2014 [14]
10 66 M pancytopenia hypopharyngeal carcinoma chemo and radio Funakosi et al. 2011 [15]
11 75 M pancytopenia CLL chemo Sadrzadeh et al. 2012 [16]
12 42 M pancytopenia ALL chemo Gupta et al. 2014 [17]
13 69 M pancytopenia FL, prostate cancer chemo and radio Roquiz et al. 2014 [18]

F; female, M; male, N/A; Not available, SCT; stem cell transplant, HIV; human immunodeficiency virus, CLL; chronic lymphocytic leukemia, ALL; acute lymphocytic leukemia, FL; follicular lymphoma, chemo; chemotherapy, radio; radiotherapy, SCT; stem cell transplant.